Experimental model of non-alcoholic fatty liver disease in pregnant rats to evaluate the effectiveness of therapy

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background: The growing incidence of non-alcoholic fatty liver disease in the population contributes to the development of obstetric complications during pregnancy and demands searching effective methods of hepatoprotective therapy.

Aim: The aim of this study was to evaluate the efficacy of therapy for non-alcoholic fatty liver disease in an experimental model in pregnant rats.

Materials and methods: this experimental study was carried out on 19 female Wistar rats weighing 250–300 g, obtained from the laboratory animal nursery of SMK Stezar Ltd. (Vladimir, Russia). Using a high-fat diet, non-alcoholic fatty liver disease was simulated in the study groups as follows. Group 1 (n = 7) consisted of non-pregnant rats, group 2 comprised pregnant rats without therapy (n = 6), and group 3 included pregnant rats and intraperitoneal administration of 12 mg of the low-molecular sugar preparation from day 16 to day 20 of gestation (n = 6). During the experiment, the body weight of female rats was measured weekly. After the experiment was completed, we evaluated the blood serum levels of aspartate aminotransferase, alanine aminotransferase, ferritin, triglycerides, total cholesterol, total bilirubin, urea, total alkaline phosphatase, bile acids, glucose, C-reactive protein, cholinesterase, and malondialdehyde, as well as catalase activity. Histological examination of the rat liver was carried out using the standard method with hematoxylin and eosin staining.

Results: This study showed that high-fat diet caused oxidative stress manifested by decreased the blood catalase level and increased malonovodialdehyde in both pregnant and non-pregnant females; the blood bile acids level also increased. In pregnant rats with non-alcoholic fatty liver disease, the serum C-reactive protein and total alkaline phosphatase levels increased, the cholinesterase level decreased, and the catalase activity decreased even more. In the study group using the low-molecular sugar preparation, biochemical parameters in non-alcoholic fatty liver disease improved, probably due to the effect on lipogenesis and oxidative stress in the liver. The histological pattern was characterized by the impaired structural characteristics of hepatocytes and the circulatory bed. With the use of the low-molecular-weight sugar preparation, we noted a tendency to restore the structure of the hepatic beam area and a decrease in the manifestations of steatosis.

Conclusions: The use of the low-molecular-weight sugar preparation in the treatment of non-alcoholic fatty liver disease improves biochemical blood parameters and tends to restore the histological structure of the liver.

全文:

受限制的访问

作者简介

Elena Mozgovaia

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: elmozg@mail.ru
ORCID iD: 0000-0002-6460-6816
SPIN 代码: 5622-5674

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Saint Petersburg

Marina Kryshnia

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

编辑信件的主要联系方式.
Email: Marina._k@mail.ru
ORCID iD: 0009-0000-2502-1578

MD

俄罗斯联邦, Saint Petersburg

Alexandra Blazhenko

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: alexandradlazhenko@gmail.com
SPIN 代码: 8762-3604

MD, Cand. Sci. (Medicine)

俄罗斯联邦, Saint Petersburg

Alina Nuzhnova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: lin.panaiotis@yandex.ru
SPIN 代码: 5521-5096
俄罗斯联邦, Saint Petersburg

Gulrukhsor Tolibova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: gulyatolibova@yandex.ru
ORCID iD: 0000-0002-6216-6220
SPIN 代码: 7544-4825

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Saint Petersburg

Tatyana Tral

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: ttg.tral@yandex.ru
ORCID iD: 0000-0001-8948-4811
SPIN 代码: 1244-9631

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Saint Petersburg

Janna Toumasova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: J_toumassa@mail.ru
SPIN 代码: 2352-0755
俄罗斯联邦, Saint Petersburg

Andrey Korenevsky

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: a.korenevsky@yandex.ru
ORCID iD: 0000-0002-0365-8532
SPIN 代码: 7942-6016

Dr. Sci. (Biology)

俄罗斯联邦, Saint Petersburg

Irina Zalozniaia

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: irinabiolog2012@yandex.ru
ORCID iD: 0000-0002-0576-9690
SPIN 代码: 2488-3790

Cand. Sci. (Biology)

俄罗斯联邦, Saint Petersburg

Victoria Ganzhina

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: ganzhina040799@gmail.com
ORCID iD: 0009-0001-5225-6484
俄罗斯联邦, Saint Petersburg

Olesya Bespalova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: shiggerra@mail.ru
ORCID iD: 0000-0002-6542-5953
SPIN 代码: 4732-8089

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Saint Petersburg

参考

  1. Yu HR, Sheen JM, Hou CY, et al. Effects of maternal gut microbiota-targeted therapy on the programming of nonalcoholic fatty liver disease in dams and fetuses, related to a prenatal high-fat diet. Nutrients. 2022;14(19):4004. doi: 10.3390/nu14194004
  2. Chiavaroli V, Hopkins SA, Biggs JB, et al. The associations between maternal BMI and gestational weight gain and health outcomes in offspring at age 1 and 7 years. Sci Rep. 2021;11:20865. doi: 10.1038/s41598-021-99869-7
  3. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797–1835. doi: 10.1097/HEP.0000000000000323
  4. Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–1347. doi: 10.1097/HEP.0000000000000004
  5. D’Adamo E, Castorani V, Nobili V. The liver in children with metabolic syndrome. Front Endocrinol. 2019;10:514. doi: 10.3389/fendo.2019.00514
  6. Yodoshi T, Orkin S, Arce Clachar AC, et al. Muscle mass is linked to liver disease severity in pediatric nonalcoholic fatty liver disease. J Pediatrics. 2020;223:93–99.e2. doi: 10.1016/j.jpeds.2020.04.046
  7. Sarkar M, Grab J, Dodge JL, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020;73(3):516–522. doi: 10.1016/j.jhep.2020.03.049
  8. El Jamaly H, Eslick GD, Weltman M. Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clin Mol Hepatol. 2022;28(1):52–66. doi: 10.3350/cmh.2021.0205
  9. Del Chierico F, Nobili V, Vernocchi P, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65:451–464. doi: 10.1002/hep.28572
  10. Ge H, Wei W, Tang L, et al. CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients. Medicine. 2022;101:e29347. doi: 10.1097/MD.0000000000029347
  11. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836–1846. doi: 10.1002/hep.24001
  12. Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013;62(12):1787–1794. doi: 10.1136/gutjnl-2012-303816
  13. Pan M, Deng Y, Qiu Y, et al. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats. Phytomedicine. 2024;130:155712. doi: 10.1016/j.phymed.2024.155712
  14. Prasomthong J, Limpeanchob N, Daodee S, et al. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. Sci Rep. 2022;12(1):7022. doi: 10.1038/s41598-022-11027-9
  15. Uspenskaya YuB. Liver dysfunction in the first half of pregnancy in the practice of an obstetrician-gynecologist. Medical Alphabet. 2020;(4):33–38. EDN: BINYEC doi: 10.33667/2078-5631-2020-4-33-38
  16. Pirogova IYu, Sinitsyn SP, Chulkov VS. Clinical effi cacy of Heptrong in patients with non-alcoholic liver disease in real clinical practice (pilot study). Experimental and Clinical Gastroenterology. 2020;184(12):109–118. EDN: RRPLAE doi: 10.31146/1682-8658-ecg-184-12-109-118
  17. Gavrilov VB, Gavrilova AR, Mazhul LM. Analysis of methods for determining products of lipid peroxidation in blood serum according to a test with thiobarbituric acid. Questions of medical chemistry. 1987;33(1):118–122. (In Russ.)
  18. Goth L. A simple method for determination of serum catalaseactivity and revision of reference range. Clin Chim Acta. 1991;196:143–151. doi: 10.1016/0009-8981(91)90067-m
  19. Makarov VG, Makarova MN, editors. Physiological, biochemical and biometric indicators of the norm of experimental animals. Saint Petersburg: LEMA; 2013. 116 p. EDN: PTSRUO (In Russ.)
  20. Yushkov BG, Korneva EA, Chereshnev VA. The concept of norm in physiology and pathophysiology. Physiological constants of laboratory animals. Yekaterinburg: Ural Branch of the Russian Academy of Sciences; 2021. 864 p. EDN: XHQGVO (In Russ.)
  21. Patel S, Patel S, Kotadiya A, et al. Age-related changes in hematological and biochemical profiles of Wistar rats. Lab Anim Res. 2024;40(1):7. doi: 10.1186/s42826-024-00194-7
  22. Notova SV, Marshinskaya OV, Kazakova TV. Activity of enzymes of the antioxidant system under conditions of a high-calorie diet in Wistar and SHR rats. Journal of Medical and Biological Research. 2024;12(3):319–328. EDN: FXQNEB doi: 10.37482/2687-149.1
  23. Grasselli E, Canesi L, Portincasa P, et al Models of non-alcoholic fatty liver disease and potential translational value: the effects of 3,5-L-diiodothyronine. Ann Hepatol. 2017;16(5):707–719. doi: 10.5604/01.3001.0010.2713
  24. Chen Z, Tian R, She Z, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116–141. doi: 10.1016/j.freeradbiomed.2020.02.025
  25. Hong T, Chen Y, Li X, et al. The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD. Oxid Med Cell Longev. 2021;2021:6889533. doi: 10.1155/2021/6889533

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Biochemical blood parameters in rats with non-alcoholic fatty liver disease. 1, non-pregnant; 2, pregnant without treatment; 3, pregnant with treatment

下载 (117KB)
3. Fig. 2. Blood enzyme levels in rats with non-alcoholic fatty liver disease. 1, non-pregnant; 2, pregnant without treatment; 3, pregnant with treatment

下载 (122KB)
4. Fig. 3. Histological structure of the liver: a, small to medium vacuolar degeneration of hepatocytes (hematoxylin and eosin staining, zoom ×200); b, moderate venous ectasia with perivascular edema (hematoxylin and eosin staining, zoom ×100)

下载 (449KB)
5. Fig. 4. Histological structure of the liver: a, medium to large vacuolar degeneration of hepatocytes (hematoxylin and eosin staining, zoom ×100); b, structure of the hepatic beam area is preserved, with ectasia and anemia of the hepatic vein of the triad (hematoxylin and eosin staining, zoom ×200)

下载 (402KB)
6. Fig. 5. Histological structure of the liver: a, structure of the hepatic beam area is preserved (hematoxylin and eosin staining, zoom ×100); b, foci of large vacuolar degeneration of hepatocytes (hematoxylin and eosin staining, zoom ×200)

下载 (428KB)
7. Fig. 1. Blood chemistry parameters in rats with non-alcoholic fatty liver disease. 1: non-pregnant rats; 2: pregnant rats without treatment; 3: pregnant rats with treatment

下载 (116KB)
8. Fig. 2. Enzyme levels in rats with non-alcoholic fatty liver disease. 1: non-pregnant rats; 2: pregnant rats without treatment; 3: pregnant rats with treatment

下载 (121KB)

版权所有 © Eсо-Vector, 2024



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.